ALLO financials
Allogene Therapeutics (ALLO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ALLO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$12.36M | -$206.93M | -$190.89M | -0.87 |
| 2024 | $22.00K | $22.00K | -$273.20M | -$257.59M | -1.32 |
| 2023 | $95.00K | $95.00K | -$327.74M | -$327.26M | -2.09 |
| 2022 | $156.00K | -$14.14M | -$335.54M | -$340.41M | -2.38 |
| 2021 | $114.09M | $114.09M | -$180.19M | -$182.05M | -1.34 |
| 2020 | $0.00 | -$11.54M | -$258.24M | -$250.22M | -2.08 |